Researcher
Koen Vercauteren
- Disciplines:Immunology, Laboratory medicine
Affiliations
- Department of Uro-gynaecology (Department)
Member
From1 Oct 2016 → 30 Sep 2017 - Department of Clinical chemistry, microbiology and immunology (Department)
Member
From1 Sep 2010 → 30 Sep 2018
Publications
1 - 10 of 25
- Prospective multicenter comparison of urine culture with PCR on dried blood spots using 2 different extraction and PCR methods in neonates suspected for congenital cytomegalovirus infection(2020)
Authors: Koen Vercauteren, Annelies Keymeulen, Ludo Mahieu, Veerle Cossey, Alexandra Casaer, Christine Van Mol, Koenraad Smets, Elizaveta Padalko
- Expansion, in vivo-ex vivo cycling, and genetic manipulation of primary human hepatocytes(2020)
Authors: Eleftherios Michailidis, Koen Vercauteren, Liliana Mancio-Silva, Linda Andrus, Cyprien Jahan, Inna Ricardo-Lax, Chenhui Zou, Mohammad Kabbani, Paul Park, Corrine Quirk, et al.
Pages: 1678 - 1688 - Tracking HCV protease population diversity during transmission and susceptibility of founder populations to antiviral therapy(2017)
Authors: Tanvi Khera, Daniel Todt, Koen Vercauteren, C Patrick McClure, Aliasghar Farhoudi Moghadam, Sabin Bhuju, Robert Geffers, Thomas F Baumert, Eike Steinmann, Thomas Pietschmann, et al.
Pages: 129 - 137 - A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection in vitro and in vivo(2017)
Authors: Isabelle Desombere, Ahmed Atef Ahmed Abouzeid Mesalam, Richard A Urbanowicz, Zhen-Yong Keck, Aliasghar Farhoudi Moghadam, Koen Vercauteren, Karin Weening, Thomas F Baumert, Arvind H Patel, Steven KH Foung, et al.
Pages: 53 - 64 - Mouse systems to model hepatitis C virus treatment and associated resistance(2016)
Authors: Ahmed Atef Ahmed Abouzeid Mesalam, Koen Vercauteren
- Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice(2016)
Authors: Koen Vercauteren, Richard JP Brown, Ahmed Atef Ahmed Abouzeid Mesalam, Juliane Doerrbecker, Sabin Bhuju, Robert Geffers, Naomi Van den Eede, C Patrick McClure, Fulvia Troise, Thomas Baumert, et al.
Pages: 2029 - 2034 - Characterisation of a hepatitis C virus-like particle vaccine produced in a human hepatocyte-derived cell line(2016)
Authors: L Earnest-Silveira, B Chua, R Chin, D Christiansen, D Johnson, S Herrmann, SA Ralph, Koen Vercauteren, Ahmed Atef Ahmed Abouzeid Mesalam, S Das, et al.
Pages: 1865 - 1876 - Apolipoprotein E mediates evasion from hepatitis C virus neutralizing antibodies(2016)
Authors: Catherine Fauvelle, Daniel J Felmlee, Emilie Crouchet, JiYoung Lee, Laura Heydmann, Mathieu Lefèvre, Andrea Magri, Marie-Sophie Hiet, Isabel Fofana, François Habersetzer, et al.
Pages: 206 - 217 - Flunarizine prevents hepatitis C virus membrane fusion in a genotype-dependent manner by targeting the potential fusion peptide within E1(2016)
Authors: Paula M Perin, Sibylle Haid, Richard JP Brown, Juliane Doerrbecker, Kai Schulze, Carsten Zeilinger, Markus von Schaewen, Brigitte Heller, Koen Vercauteren, Eva Luxenburger, et al.
Pages: 49 - 62 - Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibody(2015)
Authors: Laurent Mailly, Fei Xiao, Joachim Lupberger, Garrick K Wilson, Philippe Aubert, François HT Duong, Diego Calabrese, Céline Leboeuf, Isabel Fofana, Christine Thumann, et al.
Pages: 549 - U169